NCT04835220

Trial of Oral Lenalidomide Stewardship Program for Veterans

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: W.G. Bill Hefner Medical Center · Federal
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

To address the challenge of oral chemotherapy stewardship in the Veteran population, this study outlines the implementation and evaluation of a pilot program for the delivery and management of lenalidomide to increase the adherence rates. Our goal is to utilize a team-based multi-disciplinary approach using existing technological resources such as the tele-oncology program at the Salisbury VA and other VA medical centers to provide cancer care that is safe, effective, compassionate, and cost-effective. Subject will be prescribed a Lenalidomide based therapy per standard of care. Eligibility is based only on a prescription for Lenalidomide and is independent of any other concurrent treatments for myeloma. The objectives are as followed: 1. To describe the demographics and baseline clinical characteristics of veterans with newly diagnosed multiple myeloma treated with oral lenalidomide. 2. To evaluate the impact of the stewardship program (intervention) on the adherence to oral lenalidomide.

Conditions

• Medication Compliance

Interventions

Type	Name	Description
OTHER	Telehealth Calls	The telehealth nurse will record data in a case report form within the VA REDCap electronic data capture system that is stored within the VA firewall.

Timeline

• Start date: 2021-03-26
• Primary completion: 2024-03-26
• Completion: 2024-03-26
• First posted: 2021-04-08
• Last updated: 2023-02-28

Locations

1 site across 1 country: United States